• No results found

Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Can Interact with the Nuclear Mitotic Apparatus Protein To Regulate Genome Maintenance and Segregation

N/A
N/A
Protected

Academic year: 2019

Share "Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Can Interact with the Nuclear Mitotic Apparatus Protein To Regulate Genome Maintenance and Segregation"

Copied!
13
0
0

Loading.... (view fulltext now)

Full text

(1)

JOURNAL OFVIROLOGY, July 2008, p. 6734–6746 Vol. 82, No. 13 0022-538X/08/$08.00⫹0 doi:10.1128/JVI.00342-08

Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Kaposi’s Sarcoma-Associated Herpesvirus-Encoded LANA Can

Interact with the Nuclear Mitotic Apparatus Protein To

Regulate Genome Maintenance and Segregation

Huaxin Si,

1

Subhash C. Verma,

1

Michael A. Lampson,

2

Qiliang Cai,

1

and Erle S. Robertson

1

*

Department of Microbiology and the Tumor Virology Program of the Abramson Comprehensive Cancer Center, School of Medicine,

University of Pennsylvania, Philadelphia, Pennsylvania 19104,1and Department of Biology, University of Pennsylvania,

Philadelphia, Pennsylvania 191042

Received 16 February 2008/Accepted 9 April 2008

Kaposi’s sarcoma-associated herpesvirus (KSHV) genomes are tethered to the host chromosomes and partitioned faithfully into daughter cells with the host chromosomes. The latency-associated nuclear antigen (LANA) is important for segregation of the newly synthesized viral genomes to the daughter nuclei. Here, we report that the nuclear mitotic apparatus protein (NuMA) and LANA can associate in KSHV-infected cells. In synchronized cells, NuMA and LANA are colocalized in interphase cells and separate during mitosis at the beginning of prophase, reassociating again at the end of telophase and cytokinesis. Silencing of NuMA expression by small interfering RNA and expression of LGN and a dominant-negative of dynactin (P150-CC1), which disrupts the association of NuMA with microtubules, resulted in the loss of KSHV terminal-repeat plasmids containing the major latent origin. Thus, NuMA is required for persistence of the KSHV episomes in daughter cells. This interaction between NuMA and LANA is critical for segregation and maintenance of the KSHV episomes through a temporally controlled mechanism of binding and release during specific phases of mitosis.

Kaposi’s sarcoma-associated herpesvirus (KSHV) is a gam-maherpesvirus that is associated with Kaposi’s sarcoma, body cavity-based lymphomas (BCBL), and multicentric Castle-man’s disease (48). During latent infection, in which no prog-eny virus is produced, KSHV genomes are maintained as mul-tiple episomes in the host cells. In a lifelong latent state, KSHV genomic DNA exists as a closed circular episome, similar to the host chromosomal DNA, packaged onto the nucleosomes with cellular histones (11, 49, 54). KSHV genomes are replicated once per cell cycle and are partitioned faithfully into daughter cells, along with host chromosomes, during mitosis (29, 62, 63). The association of KSHV DNA with host chromosomes was shown to be mediated by the latency-associated nuclear anti-gen (LANA), which acts as a linker to tether viral DNA onto to the host chromosomes (4, 11, 64).

LANA, encoded by open reading frame 73 (ORF73), is consistently expressed in Kaposi’s sarcoma lesions and is cru-cial for episome maintenance in proliferating cells (4, 36). LANA, a large nuclear protein (222 to 234 kDa) with a mul-tifunctional role, is critical for episome maintenance and on-cogenesis mediated by KSHV (64). LANA has three distinct domains: a proline-rich N-terminal region, which is important for its binding with host chromosomes; a long glutamic acid-rich internal repeat domain; and a carboxy-terminal domain

(64). LANA has been shown to modulate cellular transcription by altering various transcription factors, such as transcription factor 4/cyclic AMP response element binding protein 2, mSin3A, CBP, RING3, and GSK-3b (37, 39, 64); can repress the transcription activity of p53 (2, 19); and induces chromo-somal instability (55). In addition, LANA was found to interact with pRb and concurrently stimulates transcription from the cyclin E promoter (51). Furthermore, it is also important for maintenance of latency by repressing the transcriptional activ-ity of Rta, a KSHV gene that activates lytic replication (38). In addition to modulating the transcription of viral and cellular genes, LANA recruits a number of molecules to regulate rep-lication of the viral episome and the segregation of the newly synthesized genome copies to daughter nuclei by tethering to the host chromosomes (21, 40, 52, 54, 61). A simplified model suggests that LANA can mediate tethering of the KSHV ge-nome to specific components of the chromatin structure through binding of its carboxy terminus with the terminal re-peat (TR) and associating with components of the human chromatin at its amino terminus, which includes histones and MeCP2 (6, 11, 36).

Nuclear mitotic apparatus (NuMA) protein, a 238-kDa hu-man protein, is a component of the nuclear mitotic apparatus and is distributed throughout the nucleus, excluding nucleoli, in interphase cells (10, 26). In dividing cells, NuMA redistrib-utes to the spindle poles at metaphase and anaphase to orga-nize microtubule movement and to stabilize the mitotic spindle (14, 15, 34). NuMA is vital for mitosis, since microinjection of NuMA antibodies and mutations of NuMA result in a block in mitosis and formation of micronuclei (20, 68). It has an intrin-sic ability to self-assemble into fibrous structures (25, 26) and to interact with a number of essential mitotic components,

* Corresponding author. Mailing address: Department of Microbi-ology and the Abramson Comprehensive Cancer Center, School of Medicine, University of Pennsylvania, 202E Johnson Pavilion, 3610 Hamilton Walk, Philadelphia, PA 19104. Phone: (215) 746-0114. Fax: (215) 898-9557. E-mail: erle@mail.med.upenn.edu.

† Supplemental material for this article can be found at http://jvi .asm.org/.

Published ahead of print on 16 April 2008.

6734

on November 8, 2019 by guest

http://jvi.asm.org/

(2)

including microtubules (17, 28), dynein/dynactin (47), and the mammalian Pins homolog, LGN (16). The structure of NuMA resembles the intermediate filaments, because of the coiled-coil and globular-head domains, and it may also form ordered structures in the interphase nucleus (1, 26). NuMA has also been shown to bind with the DNA matrix attachment regions (44), and the dissociation precedes DNA degradation during apoptosis (67). Recently, it has been shown that NuMA can influence the organization and maintenance of higher-order chromatin structure associated with the differentiation of mammary epithelium (1). These studies suggest that NuMA has multiple functions in cell cycle progression.

Although it has been shown that the KSHV episomes are associated with host chromosomes and maintain constant ep-isomal copies after successive passages, the underlying mech-anism of the maintenance and segregation of the KSHV ge-nome during cell division is largely unknown. Here, we show that NuMA and LANA can interact with each other during interphase and that this interaction is temporally lost as the cells enter mitosis. This interaction also involves the molecular motor complex dynein/dynactin and microtubules, as inhibition of NuMA function by blocking its association with dynein/ dynactin and microtubules resulted in loss of episomes in the daughter cells. Thus, the interaction of NuMA with LANA contributes to KSHV genome maintenance and segregation.

MATERIALS AND METHODS

Plasmids, antibodies, and cell lines.pA3M-LANA, the pA3M-LANA deletion constructs carrying the c-myc-tagged ORF73 amino-terminal domain (amino acids [aa] 1 to 435) and carboxy-terminal domain (aa 752 to 1162), and red fluorescent protein (RFP)-LANA were used as expression vectors and were described previously (24). The pA3M-LANA deletion constructs carrying Myc-tagged ORF73 aa 840 to 963 and aa 840 to 1067 were constructed by PCR amplification from pA3M LANA carboxy-terminal constructs. pBSpuro-EGFP-3TR was constructed by subcloning the puromycin resistance expression cassette from pBABEpuro into the SalI and ClaI sites of pBS-EFGP (Stratagene Inc., La Jolla, CA) containing multiple cloning sites. The complete TR unit of KSHV (801 bp) was excised from a cosmid clone, Z6, with restriction endonuclease NotI and ligated into pBSpuro at the NotI site to obtain pBSpuro-EGFP-3TR, which contains three copies of the TR. GFP-NuMA plasmid expressing GFP-tagged NuMA protein was obtained from Andreas Merdes (University of Edinburgh, Edinburgh, United Kingdom) (46). RFP-p150-CC1 expressing aa 217 to 548 of the p150Gluedsubunit of dynactin was obtained from Trina A. Schroer (Johns

Hopkins University, Baltimore, MD) (50). LGN plasmid expressing Myc-tagged LGN protein was obtained from Q. Du (Medical College of Georgia, Augusta) (17). Myc-tagged proteins were detected using mouse hybridoma 9E10 obtained from the University of Michigan Hybridoma Core Facility. NuMA protein was detected with goat anti-NuMA antibody obtained from Santa Cruz Biotechnology (Santa Cruz, CA).

The KSHV-negative cell lines BJAB and DG75 and the KSHV-positive cell lines BC-3 and BCBL1 were cultured in RPMI 1640 medium supplemented with 7% fetal bovine serum, 2 mML-glutamine, and penicillin-streptomycin (5 U/ml and 5␮g/ml, respectively). The human embryonic kidney 293 (HEK293) cell line and human osteosarcoma cell line U2OS were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 5% fetal bovine serum, 2 mM

L-glutamine, and penicillin-streptomycin (5 U/ml and 5␮g/ml, respectively). All cell lines were grown at 37°C in a humidified environment supplemented with 5% CO2.

Western blot analysis.Electrophoresed proteins were blotted onto 0.45-␮m nitrocellulose membranes (Osmonics, Inc., Minnetonka, MN) at 100 V for 1 to 2 h. The blots were blocked with 5% milk in phosphate-buffered saline (PBS) and washed three times with TBST buffer (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Tween 20) before overnight incubation with the mouse 9E10 hybridoma or goat anti-NuMA (Santa Cruz Inc., Santa Cruz, CA) at 4°C. The blots were washed three times with TBST and incubated with appropriate AlexaFluor 680 or IRDye 800 secondary antibody (1:10,000; Molecular Probes, Carlsbad, CA).

The membranes were scanned with an Odyssey Infrared scanner (Li-Cor Bio-sciences, Lincoln, NE). Densitometric analysis was performed with the Odyssey scanning software.

Cell cycle arrest and synchronization.U2OS cells transfected with green fluorescent protein (GFP)-NuMA and RFP-LANA were serum starved to syn-chronize the cells in G0/G1phase and subjected to double thymidine treatment

to synchronize the cells in S phase and nocodazole to synchronize them in mitosis. In brief, for G0phase synchronization, the cells were washed twice with

serum-free DMEM and incubated for 48 h in the absence of serum. The cells were released from starvation by the addition of fetal bovine serum to 20%. To synchronize the cells in S phase, the cells were treated with 2 mM thymidine for 22 h, grown in DMEM with 5% serum for 10 h, and treated with 2 mM thymidine again for 14 h. The cells were treated with 1.5␮g/ml nocodazole for 5 h for mitotic synchronization. The cells were released from the treatment by washing them twice in 1⫻PBS and analyzed by live-cell microscopy. The fixed cells were washed again twice with PBS and stained with DAPI (4⬘,6⬘ -diamidino-2-phe-nylindole). The slides were examined with an Olympus Fluoview FV300 confocal microscope, and images were analyzed with FLUOVIEW software (Olympus Inc., Melville, NY).

Immunofluorescence assays.BC3 and BJAB cells were washed with PBS and spread evenly on a slide. The cells were fixed with 1:1 methanol/acetone for 10 min at⫺20°C, dried, and rehydrated with PBS. For blocking, cells were incu-bated with PBS containing 3% bovine serum albumin and 1% glycine for 30 min. The cells were then cross-reacted with appropriate antibodies. Slides were de-tected with 1:1,000 chicken anti-goat and then goat anti-mouse or -rabbit immu-noglobulin-fluorescein isothiocyanate-conjugated secondary antibodies. The slides were examined with a Fluoview FV300 (Olympus Inc., Melville, NY) confocal microscope, and the images were analyzed with FLUOVIEW software (Olympus Inc., Melville, NY). An average of 20 scans per cell were obtained for Z-stack analysis.

Live-cell imaging.To examine the accurate time point for association of NuMA and LANA, U2OS cells transfected with GFP-NuMA and RFP-LANA and synchronized in S phase or mitosis were harvested by washing them twice in 1⫻PBS. Coverslips with cells were mounted in Rose chambers in L15 medium supplemented with 10% fetal bovine serum. The temperature was maintained at 37°C with a custom-made microscope stage heater. U2OS cells were filmed on a Leica inverted microscope equipped with a 63⫻1.4-numerical-aperture (NA) PlanApo objective lens. Images were recorded at 5-minute intervals.

Immunoprecipitation.For immunoprecipitation, 2⫻107transfected HEK293

cells or 8⫻107

BJAB and BC-3 cells were lysed on ice with 1 ml of RIPA buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 0.1% NP-40, 1 mM EDTA [pH 8.0]) supplemented with protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 10

␮g of pepstatin/ml, 10␮g of leupeptin/ml, and 10␮g of aprotinin/ml). The lysates were centrifuged at high speed to remove the cell debris. A control serum was used to preclear the lysate before it was incubated with specific antibodies. The precleared lysates were then incubated with anti-NuMA or anti-LANA antibody overnight at 4°C with rotation and further incubated with protein A and G Sepharose beads at 4°C for 1 h with rotation. The resulting immunoprecipitates were collected by centrifugation at 2,000⫻gfor 3 min at 4°C, and the pellets were washed four times with 1 ml of ice-cold RIPA butter. The immunoprecipi-tated pellets were resuspended in 30␮l of 2⫻sodium dodecyl sulfate (SDS) protein sample buffer (62.5 mM Tris [pH 6.8], 40 mM dithiothreitol, 2% SDS, 0.025% bromophenol blue, and 10% glycerol) and then resolved on SDS-poly-acrylamide gel electrophoresis (PAGE) with an 8% polySDS-poly-acrylamide gel. The separated proteins were transferred to a nitrocellulose membrane. Western blot analysis was performed for the detection of LANA protein by the use of an anti-rabbit polyclonal antibody. Similarly, reverse immunoprecipitation with an anti-LANA polyclonal serum was performed for BJAB and BC-3 cells, which were probed for the detection of NuMA coimmunoprecipitation (co-IP) with LANA.

Short-term replication assay.pBSpuro-EGFP containing three copies of the TR was cotransfected into HEK293 and DG75 cells in four sets: (i) without LANA expression, (ii) with LANA expression, (iii) with LANA and LGN ex-pression, and (iv) with LANA and RFP-N1-p150-CC1 expression vector. Twenty-four hours posttransfection, 1⫻puromycin (2␮g/ml) was added to the cells for selection. Relative numbers of GFP-expressing cells, which was the measure of the presence of TR plasmids and protein expression, were measured at 1, 5, and 9 days posttransfection. To measure survival, the cells at each time point were trypsinized and counted using trypan blue exclusion. To isolate DNA template for real-time tests, plasmid DNA was extracted using a modified Hirt’s proce-dure. Briefly, medium from the six-well plates was removed and the cells were washed with 1⫻PBS, followed by lysing the cells in plates with a 1:2 mixture of solutions I and II (solution I, Tris, glucose, and EDTA; solution II, SDS and

on November 8, 2019 by guest

http://jvi.asm.org/

(3)

NaOH). The lysed cells were transferred to a tube, and 1.5 volumes of solution III (3 M potassium acetate) were added, followed by incubation on ice for 10 min and centrifugation at 8,000 rpm for 10 min. The supernatant was further ex-tracted with phenol using phenol-chloroform-isoamyl alcohol, and DNA was precipitated using 0.6 volume of 2-propanol. The pellet was dried, dissolved in Tris-EDTA with RNase, and incubated at 37°C for 30 min, followed by protein-ase K treatment. Proteins were removed by a second round of phenol extraction, followed by precipitation of DNA. The extracted DNA was dissolved in Tris-EDTA buffer.

Real-time PCR analysis of viral and cellular transcription.Quantitative real-time PCR was performed in a total volume of 25␮l, including 12.5␮l of Sybr green PCR Master Mix (New England Biolabs, Beverly, MA). The GAPDH (glyceraldehyde-3-phosphate dehydrogenase) content in each sample was first amplified as an internal control to normalize DNA input for TR amplification. DNA samples were then amplified with primers (forward, 5⬘GGGGGACCCC GGGCAGCGAG 3⬘, and reverse, 5⬘ GGCTCCCCCAAACAGGCTCA 3⬘) flanking TR nucleotides 677 to 766.

RNA interference (RNAi).Small interfering RNAs (siRNAs) complementary to the GGCGUGGCAGGAGAAGUUC fragment of NuMA (8) were cloned into the pSIREN vector according to the instructions of the manufacturer (Clon-tech, Palo Alto, CA) to generate the si-NuMA construct. pSIREN vector with luciferase target sequence was used as a control. Ten million HEK293 and BJAB cells were transfected by electroporation. NuMA knockdown stable cells were selected and maintained in 4␮g/ml puromycin.

RESULTS

NuMA interacts with the carboxy-terminal domain of KSHV-encoded LANA. LANA is consistently expressed in KSHV-infected cells and contains three distinct domains (64). The carboxy terminus is important for interaction with the TRs, as well as other cellular proteins (Fig. 1A). A yeast

two-FIG. 1. The carboxy terminus of LANA binds with NuMA. (A) Schematic showing the domains of the LANA protein. LANA contains two nuclear localization sequences (NLS), a proline-rich domain (P-rich) and a glutamine-rich repeat region (Q-rich), an acidic domain (AD), and a putative leucine zipper (L-Zipper). C-terminal LANA mediates TR DNA binding, Brd2, MeCP2, pRb binding, and chromosome association. Brd2, bromodomain containing 2. (B) GST, GST-LANA-N, and GST-LANA-C fusion proteins were expressed inEscherichia coliand purified with glutathione-Sepharose beads. Nuclear extracts from BCBL-1 cells were incubated with either GST control or GST-LANA truncations normalized by Coomassie staining. The precipitated proteins were resolved by SDS-PAGE and detected with goat anti-NuMA antibody. In each case, 5% of the cell lysates were used as input for comparison. PC, precleared fraction. (C) Twenty million HEK293T cells were transfected with 20␮g of GFP-NuMA and 20␮g of either pA3M-LANA-C or pA3M-LANA-N expression plasmid. The cells were harvested at 36 h posttransfection, and the lysates were immunoprecipitated (IP) with 1␮g of anti-Myc antibody. Samples were resolved on SDS-6% PAGE and probed with anti-NuMA antibody. LANA truncations were detected with 9E10 Myc hybridoma supernatant. (D) Twenty million HEK293T cells were transfected with 20 ␮g of GFP-NuMA and 20␮g of pA3M-LANA expression plasmids as indicated. The cells were harvested at 36 h and were immunoprecipitated with 1␮g of anti-Myc antibody. Samples were resolved on SDS-6% PAGE and immunoblotted with anti-NuMA antibody to detect NuMA and 9E10 Myc hybridoma for LANA. (E) Fifty million KSHV-positive and negative BCBL1 and BJAB cells, respectively, were harvested and immunoprecipitated with 3␮l of polyclonal anti-NuMA antibody. Reverse immunoprecipitations were performed with 3␮l of rabbit anti-LANA antibody. LANA and NuMA were detected using the respective antibodies. (F) Twenty million HEK293T cells were transfected with 20␮g of GFP-NuMA and 20␮g of either pA3M-LANA aa 840 to 963 or pA3M-LANA aa 840 to 1067 expression plasmid. The cells were harvested at 36 h and immunoprecipitated with 1␮g of anti-Myc antibody.

6736 SI ET AL. J. VIROL.

on November 8, 2019 by guest

http://jvi.asm.org/

[image:3.585.65.517.70.381.2]
(4)

hybrid screen, using the carboxy terminus of LANA as bait with a cDNA library from lymphoblastoid cell lines, identified NuMA as a candidate LANA-interacting molecule. Addition-ally, recent data from a proteomic study using the carboxy terminus of LANA also detected NuMA, suggesting strong association of NuMA with LANA (31). To further corroborate the interaction, we performed GST-binding assays using vec-tor, amino terminus, and the carboxy terminus of LANA fused to GST (Fig. 1B) with the nuclear extracts from KSHV-positive BCBL1 cells. Western blot analysis detecting NuMA indicated a specific association of NuMA with the carboxy terminus of LANA (Fig. 1B).

The interaction of LANA with NuMA was also confirmed by co-IP analysis. co-IP was performed using cell lysates from HEK293T cells expressing NuMA and Myc-tagged amino-ter-minal LANA (aa 1 to 435) or carboxy-teramino-ter-minal LANA (aa 762 to 1162). The cell lysates were subjected to immunoprecipita-tion with anti-Myc antibody, and the coimmunoprecipitated NuMA was detected by anti-NuMA antibody. The results showed that the NuMA protein was detected only with the carboxy terminus of LANA (Fig. 1C). Therefore, GST binding and co-IP assays demonstrated that NuMA is a binding partner of LANA and specifically associates at the carboxy terminus of LANA.

LANA can associate with NuMA as a complex in human cells.To determine if this association could also be seen for full-length LANA, lysates from HEK293T cells expressing Myc-tagged LANA and NuMA were subjected to co-IP analysis. Cell lysates were subjected to anti-Myc antibody immunoprecipi-tation and the coimmunoprecipitated protein, NuMA, was de-tected by immunobloting using anti-NuMA antibodies. Immuno-precipitation with anti-Myc antibody and subsequent detection with anti-NuMA antibody showed that anti-Myc antibody pre-cipitated NuMA protein only when LANA was present (Fig. 1D, lane 1). As expected, LANA was detected in cells trans-fected with pA3M-LANA and immunoprecipitated with anti-Myc antibody (Fig. 1D). These results demonstrated that NuMA coimmunoprecipitated specifically with LANA and could form a complex in the cells.

To determine the interaction of NuMA and LANA in KSHV-positive cells, a co-IP assay was performed using the KSHV-positive cell line BCBL1 and a negative cell line, BJAB. Immunoprecipitation with anti-NuMA antibody and subse-quent detection with anti-LANA antibody showed that NuMA precipitated LANA from the KSHV-positive cells (Fig. 1E). Reverse co-IP analysis with anti-LANA antibody from BCBL1 and BJAB cells showed that NuMA was coimmunoprecipi-tated only from the KSHV-positive cells (Fig. 1E). These re-sults indicate that NuMA is capable of forming a complex with LANA in KSHV-infected cells, as well as in cells expressing exogenous LANA.

The residues located between aa 840 and 963 of the carboxy terminus of LANA are responsible for association with NuMA.

The carboxy-terminal domain of LANA has been shown to be involved in various functions, including binding to the TRs and transcriptional modulation (65). To determine the minimal residues of LANA responsible for NuMA interaction, we ex-pressed two truncations of the carboxy terminus of LANA tagged with the Myc epitope, along with NuMA, in HEK293T cells. Immunoprecipitation analysis with anti-Myc antibody

and subsequent detection with anti-NuMA antibody showed that NuMA was precipitated with LANA carboxy-terminal polypeptide located between amino acid residues 840 and 1067. Further truncation of the carboxy terminus to a domain located within amino acid residues 840 to 963 also showed binding (Fig. 1F). Therefore, the residues located between aa 840 and 963 of the carboxy terminus of LANA are responsible for association with NuMA.

NuMA and LANA associate in a cell cycle-dependent man-ner.To further confirm the association of LANA and NuMA, we cotransfected RFP-LANA and GFP-NuMA expression constructs into U2OS cells and analyzed the distribution of fluorescence at different stages of the cell cycle by confocal microscopy (see Materials and Methods).

To examine the distribution of LANA relative to the cen-trosome and NuMA, the above-mentioned transfected cells were synchronized at the different stages of the cell cycle, assessed by the state of chromosome condensation as seen by DAPI staining (Fig. 2). On average, 30 cells were viewed at each stage described below. In interphase cells, NuMA was present throughout the nucleus, except for the nucleolus (Fig. 2A). At this stage, LANA was seen throughout the nuclei and shared compartments similar to those of NuMA (Fig. 2A). On extending mitosis, the redistribution of the NuMA protein commenced early in prophase and appeared to coincide with chromosome condensation. However, NuMA was not a com-ponent of the mitotic chromosome. In cells with condensed DNA, LANA was distinctly separated from NuMA signals but was still distributed on the condensed chromosomes (Fig. 2B). In the mid-prometaphase, while the NuMA proteins began to form spindles, LANA was still condensed on the chromosomes (Fig. 2C). However, in metaphase, LANA signals on the chro-mosomes were aligned with the spindle equator, whereas NuMA was detected at the spindle poles (Fig. 2D). In an-aphase, the spindle poles as seen by NuMA staining moved further apart, and the sister chromatids, as well as LANA, separated and moved toward the respective spindle poles (Fig. 2E). The two groups of sister chromosomes then became two well-separated sister nuclei, followed by division of the cyto-plasm (cytokinesis) in telophase (9). During this process, NuMA reassociates early with the reforming nuclei, once again colocalizing with LANA, which is associated with the decon-densed chromosomes (Fig. 2F). Thus, LANA and NuMA can occupy the same nuclear compartment in a cell-cycle-depen-dent manner during interphase. In interphase, both LANA and NuMA were seen diffusely associated throughout the nuclei and stayed in the same compartments. However, the proteins efficiently separated once the cells entered mitosis. NuMA was concentrated and formed new spindle poles, whereas LANA remained on the chromosomes. After the segregation of daughter cells and reformation of the nuclei, the association was once again reestablished, and NuMA again redistributed to the nucleus of each daughter cell (Fig. 2).

LANA can colocalize with NuMA during interphase but is lost as the cells enter mitosis. As seen above, NuMA and LANA resided in the same compartment during certain phases of the cell cycle. Therefore Z-stack confocal microscopic anal-ysis was performed to verify colocalization of the two proteins. To determine the colocalization of LANA and NuMA, fluo-rescent images of thezaxis were collected, together with thex

on November 8, 2019 by guest

http://jvi.asm.org/

(5)

andydimensions, from U2OS cells with coexpression of RFP-LANA and GFP-NuMA. During interphase and cytokinesis, on overlay pictures of all three dimensions, yellow signals were observed, indicating colocalization of LANA and NuMA in all three dimensions (Fig. 3A and B). Notably, in addition to the yellow signals in the overlay pictures, scattered green and red spots were also seen. This was likely due to partial colocaliza-tion, which suggests that these two proteins may also be in-volved in additional activities independent of the link to KSHV replication and genome segregation.

As cells entered mitosis, LANA remained bound to the chromosomes, and NuMA was seen condensed at both spin-dles poles (Fig. 3C). No colocalization was observed in any of the three dimensions. The results of these three-dimensional analyses suggest that LANA and NuMA do not colocalize and thus do not interact once the cell enters mitosis.

Dynamic association of LANA and NuMA in actively divid-ing livdivid-ing cells. To confirm the biological significance of the observed colocalization of LANA and NuMA in fixed cells, we investigated their intracellular movements in living U2OS cells. Moreover, in vivo imaging experiments provided us with addi-tional insights into the dynamics of NuMA and LANA associ-ation. RFP-LANA and GFP-NuMA were coexpressed in U2OS cells, and the cells coexpressing both proteins were synchronized. The movements of NuMA and LANA proteins were monitored using time-lapse fluorescence microscopy by taking images of the cotransfected cells from the S phase to the mitotic phase at 5-min intervals.

The colocalization and association of fluorescently labeled NuMA with LANA was documented in the nuclei of all 15 cells observed. The cells were synchronized by traditional double thy-midine treatment to enrich for cells in S phase. As a

representa-FIG. 2. NuMA and LANA colocalize in a cell cycle-dependent manner. U2OS cells cotransfected with GFP-NuMA and RFP-LANA were synchronized at specific cell cycle stages as indicated. GFP and RFP signals were visualized using confocal microscopy as described in Materials and Methods. The nuclei were stained with DAPI.

6738 SI ET AL. J. VIROL.

on November 8, 2019 by guest

http://jvi.asm.org/

[image:5.585.60.521.65.496.2]
(6)

tive example, fluorescent images of two cells taken at 12 time points are shown in Fig. 4 (see video S1 in the supplemental material). In the nuclei of both cells, NuMA (green) and LANA (red) were detected to colocalize as the cells progressed through S phase. As the DNA became condensed during the progression of the cell cycle, signals for both NuMA and LANA were also condensed in the nuclei (Fig. 4, 15 h to 15 h 20 min). However, the green signal became more condensed at 15 h 25 min after release from thymidine treatment. Thereafter, the two proteins were seen to separate as NuMA became more condensed and started to form spindles (Fig. 4, 15 h 20 min to 16 h 5 min). This dynamic activity is consistent with our previous observation in fixed cells, which showed that LANA and NuMA are separated as the cells enter mitosis. NuMA molecules began to assemble at the poles in early prophase, while LANA signals were predominantly seen on the condensed chromosomes.

[image:6.585.129.455.67.484.2]

We also monitored GFP-NuMA- and RFP-LANA-coex-pressing cells after synchronization in mitosis. A representative cell undergoing mitosis with GFP-NuMA and RFP-LANA ex-pression is shown in Fig. 5 (see video S2 in the supplemental material). Based on monitoring cells over a period of 3 h, as seen by the position of LANA on the chromosome, this cell proceeded from prophase to telophase and eventually formed two daughter cells. At 50 min after release from the treatment, highly condensed chromosomes and spindle poles were formed, and the chromosomes began to align at the central plane of the cell (Fig. 5). A clear metaphase plate was seen at 70 min, and the cell proceeded to anaphase at 100 min. The sister chromatids were pulled apart toward the spindle poles, and the cell membrane was clearly narrowed at the midpoint as the two daughter cells were generated. In this series of studies, the daughter cells were formed at 115 min. During the entire

FIG. 3. Colocalization of NuMA and LANA in U2OS cells. U2OS cells expressing GFP-NuMA and RFP-LANA were synchronized at interphase (A), cytokinesis (B), and metaphase (C). GFP-NuMA and RFP-LANA proteins were visualized by confocal microscopy. The nuclei were counterstained with DAPI. The images were analyzed with FLUOVIEW software (Olympus), and the colocalization of the two proteins is shown in bothxandysections.

on November 8, 2019 by guest

http://jvi.asm.org/

(7)

mitosis process, both LANA and NuMA signals were in sepa-rate compartments and were not colocalized. However, these proteins colocalized (as seen by the yellow color) when the chromosomes began to decondense in the daughter cells at 125 min (Fig. 5). More intense signals demonstrating colocaliza-tion were seen at 150 min, as the yellow overlay was clearly dominant in the nuclei (Fig. 5). Taken together, these dynamic studies clearly showed that NuMA and LANA colocalized during interphase, separated at the beginning of mitosis, and reassociated in the daughter cells when the cells exited mitosis.

NuMA is required for efficient maintenance of KSHV-TR.In mammalian cells, dynein, dynactin, and microtubules assemble to form a complex required for spindle assembly and mainte-nance (50). NuMA binds directly to stationary microtubules and anchors other microtubules at the spindle pole through interaction with dynactin and the attached dynein motor (Fig.

6A) (46). In somatic cells, this interaction is restricted to mi-tosis, because NuMA is segregated to the nucleus during in-terphase and spatially separated from cytoplasmic dynein and dynactin by the nuclear membrane. Additionally, previous pro-teomic studies from our laboratory have shown that dynein can bind to LANA (31, 56). Thus, we wanted to see if these pro-teins were functionally involved in KSHV genome persistence. In an initial examination of expression pattern, NuMA, LANA, and␤-tubulin were investigated in KSHV-positive (BC-3) cells. NuMA and tubulin were colocalized in cells undergoing pro-metaphase and pro-metaphase (Fig. 6B). LANA was distributed throughout the chromosome and did not show colocalization with either NuMA or␤-tubulin (Fig. 6B).

[image:7.585.108.474.66.481.2]

To elucidate the functional role of NuMA in maintenance of the KSHV genome, we used a dominant-negative molecule of dynactin, p150-CC1, to block the NuMA function (33, 50).

FIG. 4. NuMA and LANA separate during prophase. U2OS cells transfected with GFP-NuMA and RFP-LANA were synchronized at S phase. Cells released from treatment continued to grow in a chamber in L15 medium supplemented with 10% fetal bovine serum. U2OS cells were filmed on a Leica inverted microscope equipped with a 63⫻1.4-NA PlanApo objective lens. Images were recorded at 5-minute intervals and analyzed with Image J software. Selected frames from the two-color time-lapse recording are shown. Arrows in Phase panels indicate the cells analyzed for GFP-NuMA and RFP-LANA.

6740 SI ET AL. J. VIROL.

on November 8, 2019 by guest

http://jvi.asm.org/

(8)

p150-CC1 is a truncated polypeptide consisting of aa 217 to 548 of the p150Gluedsubunit of dynactin and has been shown to

bind dynein in vitro and also to inhibit NuMA function (33, 50). NuMA binds directly to microtubules through its micro-tubule binding domain at its carboxy terminus (13). Addition-ally, we used LGN, a mammalian Pins homologue shown to be associated with the spindle poles during mitosis. Microtubules and LGN share the same domain for binding to NuMA, and so, overexpression of LGN disrupts interaction between NuMA and microtubules and further disrupts the function of NuMA (13, 14).

To determine if NuMA is important for maintenance of the KSHV genome, a short-term replication assay with the KSHV TR was conducted. Four sets of constructs were introduced into both HEK293 and DG75 cells: pBSpuro-EGFP with three copies of the TR, (i) without LANA expression, (ii) with LANA expression, (iii) with LANA and LGN expression, and

(iv) with LANA and RFP-N1-p150-CC1 expression constructs. Under puromycin selection, the relative proportions of cells expressing EGFP were calculated at 1, 3, 5, 7, and 9 days posttransfection. The ratio of cells with EGFP expression in-creased throughout the selection because the nontransfected cells were sensitive to the puromycin and thus died. In contrast to this, LANA-expressing cells showed a much higher propor-tion of enhanced-GFP-positive cells than the other groups (Fig. 6C; see Fig. S1 in the supplemental material). Cells ex-pressing LGN and p150-CC1, along with LANA, showed sig-nificantly reduced numbers of GFP-expressing cells, most likely due to the inefficient passage of the pBSpuro-EGFP-TR plasmid in the daughter cells. These data show that destabili-zation of NuMA function leads to the loss of TR-containing plasmids, suggesting its role in KSHV genome segregation.

[image:8.585.109.474.67.467.2]

The same trend in the number of TR-containing plasmids, from a similar number of cells in each set, was seen throughout

FIG. 5. NuMA and LANA reunite in daughter nuclei after cytokinesis. U2OS cells were transfected with GFP-NuMA and RFP-LANA and synchronized at mitosis. Cells released from treatment continued to grow in a chamber in L15 medium supplemented with 10% fetal bovine serum. U2OS cells were filmed on a Leica inverted microscope equipped with a 63⫻1.4-NA PlanApo objective lens. Images were recorded at 5-minute intervals and analyzed with Image J software. Selected frames from the two-color time-lapse recording are shown. Bright field images are shown under the merged images. Arrows in Phase panels indicate the cells focused for the localization of GFP-NuMA and RFP-LANA.

on November 8, 2019 by guest

http://jvi.asm.org/

(9)

the experiments in a semiquantitative PCR assay (reflected by the threshold cycle [CT] value) (Fig. 7A). A lower number of plasmid copies yields a higherCTvalue, and vice versa. The number of TR-containing plasmids decreased (increased CT

value) in cells in which NuMA function was disrupted (Fig. 7A). After normalizing the cells, we calculated the number of pBSpuro-EGFP-TR plasmids per cell in each experiment. A dramatic difference was seen in the groups with disrupted NuMA function, specifically in cells where a p150-CC1 domi-nant-negative of dynactin was expressed (Fig. 7B). These data again demonstrated that the normal function of NuMA is important for maintenance of the KSHV genome. In the ab-sence of an intact NuMA/microtubule complex, the mainte-nance of the KSHV genome exhibited a dramatic decrease in copy numbers, especially when direct interaction between NuMA and microtubules was inhibited by expression of LGN, which disrupts NuMA interaction with the microtubules (Fig. 7A and B).

Knockdown of NuMA expression by RNAi deregulates seg-regation and TR plasmid maintenance.The results described above suggested that NuMA can play a critical role in segre-gation and maintenance of the KSHV genome. To test this hypothesis more directly, we sought to disrupt the expression of endogenous NuMA using an RNAi strategy. A 19-nucleo-tide RNA sequence was reported to suppress the expression of

endogenous NuMA in several different mammalian cell lines (8). Therefore, we transfected HEK293 cells with an siRNA duplex that corresponded to specific sequences of the human NuMA. Two days after transfection, the level of endogenous NuMA was significantly reduced compared to the controls as detected by immunoblotting and in situ immunostaining exper-iments (Fig. 7C). In siRNA-treated cells, the percentage of GFP-TR-expressing cells and the relative number of TR plas-mid copies increased in controls, including si-Luc and si-Luc with LANA (Fig. 7C and D). However, the GFP-TR signals and the relative numbers of TR plasmids in experimental groups (si-NuMA expression only or expressed with LANA) showed negligible increase by day 5 and began to decrease on day 9 (Fig. 7D and E, respectively). Notably, both the percent-age of GFP-TR signals and the relative number of TR plasmids on day 9 had dramatically decreased by about 60% compared to cells with intact NuMA and exogenous LANA expression. Therefore, these results strongly support the hypothesis that NuMA is important for segregation and maintenance of the KSHV genome.

DISCUSSION

[image:9.585.111.474.69.358.2]

The identification of the cellular binding partners of KSHV-encoded LANA in this study allowed us to demonstrate for the

FIG. 6. The NuMA-dynein/dynactin complex is important in KSHV-TR maintenance. (A) Model of NuMA, dynein/dynactin, and microtubule complex. (B) Colocalization of NuMA (green) and microtubules in mitotic cells. BC-3 cells were synchronized at prometaphase (top) and metaphase (bottom). The cells were fixed and probed with anti-NuMA goat polyclonal antibody, anti-LANA rabbit polyclonal antibody, and anti-␤-tubulin mouse monoclonal antibody. Staining was visualized by confocal microscopy with donkey anti-goat (green), goat anti-rabbit (red), and donkey anti-mouse antibodies. The nuclei were counterstained with DAPI. NuMA, green; tubulin, pink; LANA, red; DNA, blue. (C) HEK293 cells were transfected with pBSpuro-EGFP-3TR and expression constructs as indicated. Twenty hours posttransfection, the cells were subjected to selection with 1␮g/ml puromycin. Expression of GFP was measured and imaged at days 1, 3, 5, 7, and 9 posttransfection. The error bars indicate standard deviations.

6742 SI ET AL. J. VIROL.

on November 8, 2019 by guest

http://jvi.asm.org/

(10)

first time that NuMA can play an important role in viral-genome maintenance and segregation. In human cells, NuMA associated with LANA in interphase and disassociated as the cells entered mitosis. NuMA is one of the nuclear matrix

[image:10.585.55.538.69.543.2]

pro-teins and can self-assemble into a fibrous network (26). In vitro, NuMA has the potential to form dimers, which can further assemble into multiarm oligomers by associating with its globular-head domains. NuMA forms a hexagonal lattice by

FIG. 7. Disruption of normal NuMA function inhibits KSHV maintenance. (A) Hirt’s DNA was extracted on days 1, 3, 5, 7, and 9 posttrans-fection from cells with pBSpuro-EGFP-3TR with LANA, LANA plus p150-CC1, and LANA plus LGN. DNA from equal numbers of cells was subjected to real-time quantitation of the TR plasmids in these three sets. RepresentativeCTvalues of the amplifications from these three samples at different time points are plotted. (B) Equal amounts of Hirt’s DNA were amplified with TR-specific primers and normalized with GAPDH copies to get the relative number of copies of TR plasmid. Relative copy numbers of the TR plasmid in a representative experiment in these samples on day 1 and day 5 are plotted. Protein expression on days 1 and 5 was detected by immunoblotting. (C) siRNAs for NuMA cloned in pSIREN vector were introduced into 10 million HEK293 cells to generate si-NuMA stable cells. pSIREN vector with firefly luciferase siRNA was used as a control. NuMA knockdown stable cells were selected and maintained in 4␮g/ml puromycin. Expression of NuMA was examined by immunoblotting and immunofluorescence. (D) si-NuMA and si-Luc stable cells were transfected with pBSpuro-EGFP-3TR and subjected to selection. Expression of GFP was measured and imaged at days 1, 5, and 9 posttransfection.The error bars indicate standard deviations. (E) Hirt’s DNA from si-Luc and si-NuMA with and without LANA-expressing cells containing pBSpuro-EGFP-3TR was extracted at days 1, 5, and 9 posttransfection. Equal amounts of Hirt’s DNA were subjected to TR amplification, and the numbers of copies of TR plasmids in these cells relative to GAPDH are plotted.

on November 8, 2019 by guest

http://jvi.asm.org/

(11)

associating with multiple molecules in the cells (26). The func-tional role of NuMA in the interphase is not entirely clear compared to that during mitosis and needs to be determined. NuMA has been shown to associate with small nuclear ribo-nucleoproteins and splicing factors involved in recycling and phosphorylation of RNA-processing factors and thus has been implicated in the regulation of DNA replication and transcrip-tion (22, 57, 70). As a nuclear matrix protein, NuMA is thought to support the nuclear shape in differentiating cells (45). In addition, a role for NuMA in DNA anchoring has also been proposed based on its interaction with matrix attachment re-gion sequences, which anchor DNA on the nuclear matrix (44). A link between NuMA and chromatin structure is implied by the observation that expression of NuMA constructs lacking C-terminal residues in HeLa cells is accompanied by redistri-bution of nuclear components, such as DNA and histone H1, to the nuclear rim (25). NuMA has also been shown to colo-calize with the multifunctional, DNA-binding, high-mobility group proteins I/Y (58) and binds to the putative transcription factor GAS41 (27). Recently, NuMA was reported to be present in chromatin compartments and can influence the or-ganization and maintenance of higher-order chromatin struc-ture associated with the differentiation of mammary epithe-lium (1). In this study, a strong association between LANA and NuMA was seen in interphase; thus, NuMA may also function as a matrix to support specific biological processes of KSHV, including genome maintenance and segregation into new daughter cells. This is the first report showing that a viral protein can interact with NuMA and that it helps in segrega-tion of the viral genome into the dividing daughter cells. A role for KSHV LANA protein in attaching the viral genome to the nuclear matrix was shown before by our group, in that CENP-F binds to LANA and helps in tethering the viral genome to the nuclear matrix (31). A human papillomavirus 16-encoded pro-tein, E7, has also been shown to colocalize with the nuclear matrix during infection (23).

The spindle apparatus is formed to move and separate sister chromatids into two daughter cells during cell divisions. After releasing from the nucleus, NuMA associates with cytoplasmic dynein/dynactin to form a complex and translocates to the spindle poles, where it organizes and tethers microtubules to the spindle poles (46). After the onset of anaphase, the asso-ciation of NuMA with dynein/dynactin is lost, and it releases from the spindle poles to allow spindle disassembly and the reformation of interphase daughter nuclei (26, 28, 46, 47). A functional role of NuMA in KSHV cell division has been sug-gested based on our observation that the maintenance of TR plasmids was inhibited on disruption of either dynein/dynac-tin association or microtubule association in the presence of NuMA. Dynein is a minus-end-directed microtubule motor that consists of multiple polypeptide chains arranged in a large multisubunit complex. Dyneins are large, multisubunit ATPases that interact with microtubules and dynactin to generate force. Dyneins are involved in the transport of particles and organelles along microtubules and in the trans-port of condensed chromosomes during mitosis (18). In our previous proteomic studies, heavy-chain dyneins have been found to bind both the KSHV TR and LANA (31, 56). Since dynein/dynactin and microtubule association are important in transportation of both NuMA and mitotic chromosomes

to the spindle poles, we speculate that NuMA may also help in efficient segregation of the replicated KSHV genome into daughter cells.

NuMA has a role in the maintenance of KSHV DNA in a cell cycle-dependent manner. In interphase, it can act as a nuclear matrix to tether the KSHV genome, which is important for persistence. However, in mitosis, it forms complexes with dynein/dynactin and microtubules, which is critical for the seg-regation of replicated viral DNA. The amino and carboxy ter-mini of LANA have different functions and can cooperate to tether the KSHV genome on human chromosomes (65). The amino-terminal LANA binds chromosomes diffusely through histones and is essential for LANA-mediated DNA replication and episome persistence (6, 11, 42). The carboxy terminus of LANA contains a TR DNA-binding region between aa 996 and 1139 that is important for mediating DNA replication and episome persistence (5, 21, 35, 41, 54). This region also medi-ates chromosome association and is important for LANA self-association (32, 36). The carboxy terminus of LANA contains a DNA-binding region and can associate with the mitotic chro-mosomes by interacting with cellular proteins, including DEK and Brd4 (32, 36, 66, 69). Interestingly, the carboxy-terminal chromatin-binding domain of LANA is thought to be impor-tant for interaction with Brd2/RING3 (66) and can bind to Brd4 through interaction with the extraterminal domain of Brd4 (69). In this study, the carboxy terminus of LANA has been shown to bind to the nuclear mitotic apparatus. The association between LANA and NuMA, we now show, involves a complex of dynein/dynactin and microtubules. The involve-ment of this motor complex indicates that NuMA is important for segregation of the KSHV genome. We further determined that NuMA binds to LANA between aa 840 and 963, which is adjacent to the TR-binding region but does not overlap with it. It is likely that other cellular proteins involved in regulation of the mitotic apparatus, as well as CENP-E and CENP-F, the members of the tethering complex, make LANA important for KSHV genome segregation.

Several lines of evidences have suggested that LANA is closely linked to the protection of infected host cells from apoptosis. First, Pim-1 is highly expressed in LANA-expressing cells, and LANA can enhance the transcription activity of the Pim-1 promoter (3). Additionally, Pim-1 can bind to the car-boxy terminus of LANA (3) and inhibit NuMA-associated apoptosis (7). Second, LANA is also closely associated with apoptosis protection in KSHV-infected cells (19, 30). LANA-expressing cells can proliferate faster and are better protected from apoptosis (3, 19, 30, 55). Third, LANA was shown to be a good target molecule for KSHV therapy through induction of apoptosis (12). Finally, reduced levels of LANA lead to p53 activation and result in G1cell cycle arrest, DNA fragmenta-tion, and oxidative-stress-mediated apoptosis (12). Moreover, disruption of the p53-MDM2-LANA complex by the MDM2 inhibitor Nutlin-3a selectively induced massive apoptosis in PEL cells (53). However, the mechanism involved in apoptotic protection by LANA is largely unknown. Several observations suggest that the apoptotic degradation of NuMA may be re-lated to chromatin condensation and micronucleation (43). Four apoptotic cleavage sites were identified at a junction between the globular tail and the central coiled-coil domains of NuMA. A NuMA deletion mutant missing the entire cleavage

6744 SI ET AL. J. VIROL.

on November 8, 2019 by guest

http://jvi.asm.org/

(12)

region resisted degradation and protected cells from nuclear disruption upon apoptotic attack (43). NuMA is specifically targeted by human rhinovirus type 1B or measles virus during virus-induced programmed cell death (59). A virus-specific mechanism of NuMA cleavage was shown in human rhinovirus type 1B- and measles virus-infected cells and suggests that these viruses activate different sets of proteases (59). In addi-tion, NuMA may influence the kinetics of nuclear degradation during apoptosis as a caspase substrate (60). All these obser-vations suggest that NuMA is a target for virus-induced cell death and that it may also function as a downstream effecter of KSHV-mediated protection from apoptosis, as well as regula-tion of genome segregaregula-tion and persistence through interac-tion with LANA.

ACKNOWLEDGMENTS

We thank Andreas Merdes, Trina A. Schroer, and Quansheng Du for generously providing reagents. We are grateful to Thomai Gocs-tooulos and Evangelia Athanasoula for their technical support.

This work was supported by grants from the Leukemia and Lym-phoma Society of America and by public health service grants NCI CA072510, CA108461, and CA091792; NIDCR DEO017338 and DE01436; and NIAID AI067037 (to E.S.R.). E.S.R. is a scholar of the Leukemia and Lymphoma Society of America. S.C.V is supported by an NIH pathway to independence award (K99CA126182).

REFERENCES

1.Abad, P. C., J. Lewis, I. S. Mian, D. W. Knowles, J. Sturgis, S. Badve, J. Xie, and S. A. Lelievre.2007. NuMA influences higher order chromatin organi-zation in human mammary epithelium. Mol. Biol. Cell18:348–361. 2.An, F. Q., N. Compitello, E. Horwitz, M. Sramkoski, E. S. Knudsen, and R.

Renne.2004. The latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus modulates cellular gene expression and protects lym-phoid cells from P16INK4A-induced cell cycle arrest. J. Biol. Chem.280: 3862–3874.

3.Bajaj, B. G., S. C. Verma, K. Lan, M. A. Cotter, Z. L. Woodman, and E. S. Robertson.2006. KSHV encoded LANA upregulates Pim-1 and is a sub-strate for its kinase activity. Virology351:18–28.

4.Ballestas, M. E., P. A. Chatis, and K. M. Kaye.1999. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear an-tigen. Science284:641–644.

5.Ballestas, M. E., and K. M. Kaye.2001. Kaposi’s sarcoma-associated her-pesvirus latency-associated nuclear antigen 1 mediates episome persistence throughcis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J. Virol.75:3250–3258.

6.Barbera, A. J., M. E. Ballestas, and K. M. Kaye.2004. The Kaposi’s sarcoma-associated herpesvirus latency-sarcoma-associated nuclear antigen 1 N terminus is essential for chromosome association, DNA replication, and episome per-sistence. J. Virol.78:294–301.

7.Bhattacharya, N., Z. Wang, C. Davitt, I. F. McKenzie, P. X. Xing, and N. S. Magnuson.2002. Pim-1 associates with protein complexes necessary for mitosis. Chromosoma111:80–95.

8.Chang, P., M. Coughlin, and T. J. Mitchison.2005. Tankyrase-1 polymer-ization of poly(ADP-ribose) is required for spindle structure and function. Nat. Cell Biol.7:1133–1139.

9.Cleveland, D. W.1995. NuMA: a protein involved in nuclear structure, spindle assembly, and nuclear re-formation. Trends Cell Biol.5:60–64. 10.Compton, D. A., I. Szilak, and D. W. Cleveland.1992. Primary structure of

NuMA, an intranuclear protein that defines a novel pathway for segregation of proteins at mitosis. J. Cell Biol.116:1395–1408.

11.Cotter, M. A., II, and E. S. Robertson.1999. The latency-associated nuclear antigen tethers the Kaposi’s sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology264:254–264. 12.Curreli, F., A. E. Friedman-Kien, and O. Flore.2005. Glycyrrhizic acid alters

Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated ap-optosis in transformed B lymphocytes. J. Clin. Investig.115:642–652. 13.Du, M. Q., T. C. Diss, H. Liu, H. Ye, R. A. Hamoudi, J. Cabecadas, H. Y.

Dong, N. L. Harris, J. K. Chan, J. W. Rees, A. Dogan, and P. G. Isaacson. 2002. KSHV- and EBV-associated germinotropic lymphoproliferative disor-der. Blood100:3415–3418.

14.Du, M. Q., H. Liu, T. C. Diss, H. Ye, R. A. Hamoudi, N. Dupin, V. Meignin, E. Oksenhendler, C. Boshoff, and P. G. Isaacson.2001. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood97:2130–2136.

15.Du, Q., and I. G. Macara.2004. Mammalian Pins is a conformational switch that links NuMA to heterotrimeric G proteins. Cell119:503–516. 16.Du, Q., P. T. Stukenberg, and I. G. Macara.2001. A mammalian Partner of

inscuteable binds NuMA and regulates mitotic spindle organization. Nat. Cell Biol.3:1069–1075.

17.Du, Q., L. Taylor, D. A. Compton, and I. G. Macara.2002. LGN blocks the ability of NuMA to bind and stabilize microtubules. A mechanism for mitotic spindle assembly regulation. Curr. Biol.12:1928–1933.

18.Fant, X., A. Merdes, and L. Haren.2004. Cell and molecular biology of spindle poles and NuMA. Int. Rev. Cytol.238:1–57.

19.Friborg, J., Jr., W. Kong, M. O. Hottiger, and G. J. Nabel.1999. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402:889–894.

20.Gaglio, T., A. Saredi, and D. A. Compton.1995. NuMA is required for the organization of microtubules into aster-like mitotic arrays. J. Cell Biol.131: 693–708.

21.Garber, A. C., M. A. Shu, J. Hu, and R. Renne.2001. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus. J. Virol.75:7882–7892. 22.Gobert, G. N., C. N. Hueser, E. M. Curran, Q. Y. Sun, V. V. Glinsky, W. V.

Welshons, A. Eisenstark, and H. Schatten. 2001. Immunolocalization of NuMA and phosphorylated proteins during the cell cycle in human breast and prostate cancer cells as analyzed by immunofluorescence and postem-bedding immunoelectron microscopy. Histochem. Cell Biol.115:381–395. 23.Greenfield, I., J. Nickerson, S. Penman, and M. Stanley. 1991. Human

papillomavirus 16 E7 protein is associated with the nuclear matrix. Proc. Natl. Acad. Sci. USA88:11217–11221.

24.Groves, A. K., M. A. Cotter, C. Subramanian, and E. S. Robertson.2001. The latency-associated nuclear antigen encoded by Kaposi’s sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promot-ers. J. Virol.75:9446–9457.

25.Gueth-Hallonet, C., J. Wang, J. Harborth, K. Weber, and M. Osborn.1998. Induction of a regular nuclear lattice by overexpression of NuMA. Exp. Cell Res.243:434–452.

26.Harborth, J., J. Wang, C. Gueth-Hallonet, K. Weber, and M. Osborn.1999. Self assembly of NuMA: multiarm oligomers as structural units of a nuclear lattice. EMBO J.18:1689–1700.

27.Harborth, J., K. Weber, and M. Osborn.2000. GAS41, a highly conserved protein in eukaryotic nuclei, binds to NuMA. J. Biol. Chem.275:31979– 31985.

28.Haren, L., and A. Merdes.2002. Direct binding of NuMA to tubulin is mediated by a novel sequence motif in the tail domain that bundles and stabilizes microtubules. J. Cell Sci.115:1815–1824.

29.Hu, J., A. C. Garber, and R. Renne.2002. The latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J. Virol.76:11677–11687.

30.Katano, H., Y. Sato, and T. Sata. 2001. Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with in-hibition of apoptosis in HHV-8-associated malignancies. Cancer92:3076– 3084.

31.Kaul, R., S. C. Verma, and E. S. Robertson.2007. Protein complexes asso-ciated with the Kaposi’s sarcoma-assoasso-ciated herpesvirus-encoded LANA. Virology364:317–329.

32.Kelley-Clarke, B., M. E. Ballestas, V. Srinivasan, A. J. Barbera, T. Komatsu, T. A. Harris, M. Kazanjian, and K. M. Kaye.2007. Determination of Ka-posi’s sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding. J. Virol.81:4348–4356.

33.King, S. J., C. L. Brown, K. C. Maier, N. J. Quintyne, and T. A. Schroer. 2003. Analysis of the dynein-dynactin interaction in vitro and in vivo. Mol. Biol. Cell14:5089–5097.

34.Kisurina-Evgenieva, O., G. Mack, Q. Du, I. Macara, A. Khodjakov, and D. A. Compton.2004. Multiple mechanisms regulate NuMA dynamics at spindle poles. J. Cell Sci.117:6391–6400.

35.Komatsu, T., M. E. Ballestas, A. J. Barbera, B. Kelley-Clarke, and K. M. Kaye.2004. KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence. Virology319:225–236.

36.Krithivas, A., M. Fujimuro, M. Weidner, D. B. Young, and S. D. Hayward. 2002. Protein interactions targeting the latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus to cell chromosomes. J. Virol.76: 11596–11604.

37.Krithivas, A., D. B. Young, G. Liao, D. Greene, and S. D. Hayward.2000. Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepres-sor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J. Virol.74:9637–9645.

38.Lan, K., D. A. Kuppers, S. C. Verma, and E. S. Robertson.2004. Kaposi’s sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. J. Virol.78:6585–6594.

39.Lim, C., Y. Gwack, S. Hwang, S. Kim, and J. Choe.2001. The transcriptional activity of cAMP response element-binding protein-binding protein is

on November 8, 2019 by guest

http://jvi.asm.org/

(13)

ulated by the latency associated nuclear antigen of Kaposi’s sarcoma-asso-ciated herpesvirus. J. Biol. Chem.276:31016–31022.

40.Lim, C., H. Sohn, Y. Gwack, and J. Choe.2000. Latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity. J. Gen. Virol.81:2645–2652.

41.Lim, C., H. Sohn, D. Lee, Y. Gwack, and J. Choe.2002. Functional dissection of latency-associated nuclear antigen 1 of Kaposi’s sarcoma-associated her-pesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. J. Virol.76:10320–10331.

42.Lim, L. L., J. Druce, and A. C. Street.2004. Human herpesvirus type 8-as-sociated episodic multisystem illness in an HIV-infected patient in the ab-sence of hemophagocytic lymphohistiocytosis. Clin. Infect. Dis.38:1640– 1641.

43.Lin, H. H., H. L. Hsu, and N. H. Yeh.2007. Apoptotic cleavage of NuMA at the C-terminal end is related to nuclear disruption and death amplification. J. Biomed. Sci.14:681–694.

44.Luderus, M. E., J. L. den Blaauwen, O. J. de Smit, D. A. Compton, and R. van Driel.1994. Binding of matrix attachment regions to lamin polymers involves single-stranded regions and the minor groove. Mol. Cell. Biol. 14:6297–6305.

45.Merdes, A., and D. W. Cleveland.1998. The role of NuMA in the interphase nucleus. J. Cell Sci.111:71–79.

46.Merdes, A., R. Heald, K. Samejima, W. C. Earnshaw, and D. W. Cleveland. 2000. Formation of spindle poles by dynein/dynactin-dependent transport of NuMA. J. Cell Biol.149:851–862.

47.Merdes, A., K. Ramyar, J. D. Vechio, and D. W. Cleveland.1996. A complex of NuMA and cytoplasmic dynein is essential for mitotic spindle assembly. Cell87:447–458.

48.Moore, P. S., and Y. Chang.2003. Kaposi’s sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu. Rev. Microbiol.57:609–639.

49.Moore, P. S., S. J. Gao, G. Dominguez, E. Cesarman, O. Lungu, D. M. Knowles, R. Garber, P. E. Pellett, D. J. McGeoch, and Y. Chang.1996. Primary characterization of a herpesvirus agent associated with Kaposi’s sarcomae. J. Virol.70:549–558.

50.Quintyne, N. J., S. R. Gill, D. M. Eckley, C. L. Crego, D. A. Compton, and T. A. Schroer.1999. Dynactin is required for microtubule anchoring at centrosomes. J. Cell Biol.147:321–334.

51.Radkov, S. A., P. Kellam, and C. Boshoff.2000. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F path-way and with the oncogene Hras transforms primary rat cells. Nat. Med. 6:1121–1127.

52.Sakakibara, S., K. Ueda, K. Nishimura, E. Do, E. Ohsaki, T. Okuno, and K. Yamanishi. 2004. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi’s sarcoma-associated herpesvirus medi-ated by the latency-associmedi-ated nuclear antigen. J. Virol.78:7299–7310. 53.Sarek, G., S. Kurki, J. Enback, G. Iotzova, J. Haas, P. Laakkonen, M. Laiho,

and P. M. Ojala.2007. Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas. J. Clin. Investig.117:1019–1028. 54.Schwam, D. R., R. L. Luciano, S. S. Mahajan, L. Wong, and A. C. Wilson.

2000. Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies. J. Virol.74:8532–8540.

55.Si, H., and E. S. Robertson.2006. Kaposi’s sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function. J. Virol.80:697–709.

56.Si, H., S. C. Verma, and E. S. Robertson.2006. Proteomic analysis of the Kaposi’s sarcoma-associated herpesvirus terminal repeat element binding proteins. J. Virol.80:9017–9030.

57.Sparks, C. A., E. G. Fey, C. A. Vidair, and S. J. Doxsey.1995. Phosphoryla-tion of NUMA occurs during nuclear breakdown and not mitotic spindle assembly. J. Cell Sci.108:3389–3396.

58.Tabellini, G., M. Riccio, G. Baldini, R. Bareggi, A. M. Billi, V. Grill, P. Narducci, and A. M. Martelli.2001. Further considerations on the intranu-clear distribution of HMGI/Y proteins. Ital. J. Anat. Embryol.106:251–260. 59.Taimen, P., H. Berghall, R. Vainionpaa, and M. Kallajoki.2004. NuMA and nuclear lamins are cleaved during viral infection—inhibition of caspase ac-tivity prevents cleavage and rescues HeLa cells from measles virus-induced but not from rhinovirus 1B-induced cell death. Virology320:85–98. 60.Taimen, P., and M. Kallajoki.2003. NuMA and nuclear lamins behave

differently in Fas-mediated apoptosis. J. Cell Sci.116:571–583.

61.Verma, S. C., T. Choudhuri, R. Kaul, and E. S. Robertson.2006. Latency-associated nuclear antigen (LANA) of Kaposi’s sarcoma-Latency-associated herpes-virus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats. J. Virol.80:2243–2256.

62.Verma, S. C., T. Choudhuri, and E. S. Robertson.2007. The minimal repli-cator element of the Kaposi’s sarcoma-associated herpesvirus terminal re-peat supports replication in a semiconservative and cell-cycle-dependent manner. J. Virol.81:3402–3413.

63.Verma, S. C., K. Lan, T. Choudhuri, M. A. Cotter, and E. S. Robertson.2007. An autonomous replicating element within the KSHV genome. Cell Host Microbe2:106–118.

64.Verma, S. C., K. Lan, and E. Robertson.2007. Structure and function of latency-associated nuclear antigen. Curr. Top. Microbiol. Immunol.312: 101–136.

65.Verma, S. C., and E. S. Robertson.2003. Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus. FEMS Microbiol. Lett.222:155– 163.

66.Viejo-Borbolla, A., M. Ottinger, E. Bruning, A. Burger, R. Konig, E. Kati, J. A. Sheldon, and T. F. Schulz.2005. Brd2/RING3 interacts with a chro-matin-binding domain in the Kaposi’s sarcoma-associated herpesvirus laten-cy-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. J. Virol.79:13618–13629.

67.Weaver, V. M., C. E. Carson, P. R. Walker, N. Chaly, B. Lach, Y. Raymond, D. L. Brown, and M. Sikorska.1996. Degradation of nuclear matrix and DNA cleavage in apoptotic thymocytes. J. Cell Sci.109:45–56.

68.Yang, C. H., and M. Snyder.1992. The nuclear-mitotic apparatus protein is important in the establishment and maintenance of the bipolar mitotic spin-dle apparatus. Mol. Biol. Cell3:1259–1267.

69.You, J., V. Srinivasan, G. V. Denis, W. J. Harrington, Jr., M. E. Ballestas, K. M. Kaye, and P. M. Howley.2006. Kaposi’s sarcoma-associated herpes-virus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes. J. Virol.80:8909–8919.

70.Zeng, C., D. He, S. M. Berget, and B. R. Brinkley.1994. Nuclear-mitotic apparatus protein: a structural protein interface between the nucleoskeleton and RNA splicing. Proc. Natl. Acad. Sci. USA91:1505–1509.

6746 SI ET AL. J. VIROL.

on November 8, 2019 by guest

http://jvi.asm.org/

Figure

FIG. 1. The carboxy terminus of LANA binds with NuMA. (A) Schematic showing the domains of the LANA protein
FIG. 2. NuMA and LANA colocalize in a cell cycle-dependent manner. U2OS cells cotransfected with GFP-NuMA and RFP-LANA weresynchronized at specific cell cycle stages as indicated
FIG. 3. Colocalization of NuMA and LANA in U2OS cells. U2OS cells expressing GFP-NuMA and RFP-LANA were synchronized atinterphase (A), cytokinesis (B), and metaphase (C)
FIG. 4. NuMA and LANA separate during prophase. U2OS cells transfected with GFP-NuMA and RFP-LANA were synchronized at S phase.Cells released from treatment continued to grow in a chamber in L15 medium supplemented with 10% fetal bovine serum
+4

References

Related documents

‘Comparative study of vocal cord lesions using videostroboscopy, voice analysis and voice handicap index pre and postoperatively.. Submitted

Task discretion Task variety Problem solving teams Formal job descriptions Project teams Team briefings Suggestion scheme Staff survey Induction Work shadowing Off-the-job

• in state-funded primary schools, the proportion of pupils who were persistent absentees (had already missed 46 or more sessions during autumn term) decreased, from 0.5 per cent

Having con- firmed that amino acid residues 161 to 210 are necessary for Pind protein self-association and VSV transcription, it was of interest to determine whether synthetic

No: 4: Treatment of modified thiozolidine dione tablet against STZ- induced diabetic rats ( Glucose level mg / dl

Between the asthmatic groups serum potassium, serum sodium and serum magnesium of the intermittent asthmatic group is found to be better compared to the

Cumulative survival of juvenile largemouth bass injected intraperitoneally with equal doses of three LMBV isolates (SC, JW, and CL) or with virus-free cell culture

The srr7 S protein expressed in BHK cells was almost thoroughly digested with proteinase K when not treated with soMHVR, whereas a 58-kDa band was visible when it was treated